877438-46-5

Upstream product

• 18162-48-6 tert-butyldimethylsilyl chloride 
• 24393-20-2 2-(3-hydroxyphenyl)-1,3-dithiane 
• 100-83-4 meta-hydroxybenzaldehyde 
• 109-80-8 1.3-propanedithiol 
• 96013-95-5 3-(tert-butyl-dimethyl-sylanyloxy)benzaldehyde 

Downstream Products

• 877438-53-4 (3R,4R)-3-[(propane-1,3-diyldithio)-(3-tert-butyldimethylsilanyloxyphenyl)methyl]-4-[(1R,2S,5R)-2-(1-methylethyl)-5-methyl-1-cyclohexyloxy]butano-4-lactone 
• 220913-32-6 DB-67 
• 877438-60-3 (3R)-3-[(propane-1,3-diyldithio)-(4-tert-butyldimethylsilanyloxyphenyl)methyl]butano-4-lactone 
• 877438-78-3 (8R,8'R)-3,3'-bis(tert-butyldimethylsilanyloxy)-7'-oxolignano-9,9'-lactone 
• 877438-70-5 (8R,8'R)-3,3'-bis(tert-butyldimethylsilanyloxy)-7'-(propane-1,3-diyldithio)lignano-9,9'-lactone 

Relevant academic research and scientific papers

METHODS AND SYSTEMS FOR CAMPTOTHECIN ANALOG SYNTHESIS

Methods and systems for making camptothecin analogs and intermediates are provided. Aspects include safer and lower cost methodologies for making camptothecin analogs and intermediates from synthetic materials. In another aspect, the methods and systems c

Asymmetric synthesis, stereochemistry and rearrangement reactions of naturally occurring 7′-hydroxylignano-9,9′-lactones

The asymmetric synthesis of a series of (7′S,8R,8′R)-7′- hydroxylignano-9,9′-lactones is presented, among them the mammalian lignan (7′S)-hydroxyenterolactone and (7′S)-parabenzlactone, allowing the stereochemistry of natural occurring (-)-parabenzlactone